Information Library
Business transformation - Faster product development
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
QUINTILES ANNOUNCES CLINICAL PHARMACOLOGY ALLIANCE WITH ASTRAZENECA
November 2, 2009 - Quintiles has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe. -
Enabling Transformation
September 30, 2009
Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company. -
Tissue Biomarkers in Oncology Clinical Development: The Digital Advantage
September 15, 2009
The advantages of incorporating digital pathology into your oncology clinical development process. -
Rebalancing Risk to Transform R&D
June 3, 2009
A strategic approach to re-balancing the main components of biopharma company risk: portfolio, operational and resource. -
Making Headway in Shifting Winds by Maximizing Value
May 1, 2009
Three experts discuss how personalized medicine and more targeted therapies are causing organizations to change their commercial organizations. -
Setting Sail for Success by Optimizing Productivity
April 1, 2009
Quintiles Consulting Market Intelligence (Eidetics) Practice Leader James Kirk and our process optimization expert Principal Consultant Mike Hagan discuss how you can optimize productivity in your organization. -
Adrian McKemey, Ph.D.
March 25, 2009
Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting. -
Jim Featherstone, Ph.D.
March 25, 2009
Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice. -
Matthew Eberhart
March 25, 2009
Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe. -
Jay Norman
March 24, 2009
President – Quintiles Consulting Jay brings 25 years of experience in the consulting industry and a strong track record of growth, most recently with Diamond Management and Technology Consultants, where he served as President and Chief Operating Officer.